Lysosomes Contribute to Anomalous Pharmacokinetic Behavior of Melanocortin-4 Receptor Agonists

By Gong Yuping   Zhao Zhiyang   McConn Donavon   Beaudet Beth   Tallman Melanie   Speake Jason   Ignar Diane   Krise Jeffrey  

Pharmaceutical Research, Vol. 24, Iss. 6, 2007-06 ,pp. : 1138-1144

Springer Publishing Company

Access to resources Recommend Favorite

Synthesis and receptor-binding affinity of dipeptoid cholecystokinin ligands

By Araldi G.   Donati D.   Oliosi B.   Pasquarello A.   Polinelli S.   Tarzia G.   Ursini A.   van Amsterdam F.  

European Journal of Medicinal Chemistry, Vol. 31, Iss. 3, 1996-01 ,pp. : 215-220

Elsevier

Access to resources Recommend Favorite

Design and Synthesis of Dopaminergic Agonists

By  

Current Medicinal Chemistry, Vol. 23, Iss. 25, 2016-09 ,pp. : 2790-2825

Bentham Science Publishers

Access to resources Recommend Favorite

Exploration of N-arylpiperazine Binding Sites of D2 Dopaminergic Receptor

By  

Mini Reviews in Medicinal Chemistry, Vol. 15, Iss. 12, 2015-07 ,pp. : 988-1001

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacokinetic properties of newly synthesized retinoid X receptor agonists possessing a 6-[N-ethyl-N-(3-alkoxy-4-isopropylphenyl)amino]nicotinic acid skeleton in rats

By Ogasawara Akemi   Murakami Yoshiki   Yakushiji Nobumasa   Ohsawa Fuminori   Kusaba Jun-ichi   Aiba Tetsuya   Kurosaki Yuji   Kakuta Hiroki  

Drug Development and Industrial Pharmacy, Vol. 37, Iss. 9, 2011-09 ,pp. : 1060-1067

Informa Healthcare

Access to resources Recommend Favorite